Flavio Ribichini

Showing 1-15 of 15 articles

NVT ALLEGRA transcatheter heart valve for valve-in-valve procedures in failing surgical aortic bioprostheses: let us wait and see

Pighi M, Lunardi M, Ribichini F

October 4, 2019 | 10.4244/EIJV15I9A137

Coronary interventions

Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting. The GRAFFITI trial

Toth G, de Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, van Mieghem CAG, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E

July 2, 2019 | 10.4244/EIJ-D-19-00463

The promise of vascular reparative therapy in standby mode. How long before a final decision? Complete vessel wall regeneration and vascular scaffold resorption after left anterior descending reconstructions

Ribichini F, Pesarini G

July 20, 2018 | 10.4244/EIJV14I4A65

Physiologic evaluation of coronary lesions using instantaneous wave-free ratio (iFR) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation

Scarsini R, Pesarini G, Zivelonghi C, Piccoli A, Ferrero V, Lunardi M, Gottin L, Zanetti C, Faggian G, Ribichini F

January 19, 2018 | 10.4244/EIJ-D-17-00542

Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI

D’ascenzo F, Benedetto U, Bianco M, Conrotto F, Moretti C, D’Onofrio A, Agrifoglio M, Colombo A, Ribichini F, Tarantini G, D’Amico M, Salizzoni S, Rinaldi M

December 8, 2017 | 10.4244/EIJ-D-17-00198

Coronary interventions

One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)

Testa L, De Carlo M, Petrolini A, Rapetto C, Varbella F, Cortese B, Gabrielli G, Geraci S, Loi B, Boccuzzi G, Tarantini G, Fischetti D, Calabria P, Tomai F, Ribichini F, Tamburino C, Indolfi C, Bartorelli A, Petronio A, Bedogni F

July 20, 2017 | 10.4244/EIJ-D-17-00246

European expert consensus on rotational atherectomy

Barbato E, Carrié D, Dardas P, Fajadet J, Gaul G, Haude M, Khashaba A, Koch K, Meyer-Gessner M, Palazuelos J, Reczuch K, Ribichini F, Sharma S, Sipotz J, Sjögren I, Suetsch G, Szabo G, Valdés Chávarri M, Vaquerizo B, Wijns W, Windecker S, De Belder A

May 19, 2015 | 10.4244/EIJV11I1A6

The need for this supplement: beyond “exercises in style”

Ribichini F, Cuisset T

August 19, 2014 | 10.4244/EIJV10STA1

Percutaneous coronary interventions during ST-segment elevation myocardial infarction: current status and future perspectives

Diletti R, Yetgin T, Manintveld O, Ligthart J, Zivelonghi C, Zijlstra F, Ribichini F

August 19, 2014 | 10.4244/EIJV10STA4

Numbers needed to treat (lives!) and numbers needed to save (money)

Ribichini F, Taggart D, Vassanelli C

June 28, 2013 | 10.4244/EIJV9I2A28

Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS)

Ribichini F, Tomai F, Reimers B, Russo P, Borioni R, SpartÃ D, Pacchioni A, Pesarini G, Spagnolo B, De Persio G, Cremonesi A, Castriota F

August 15, 2010

The gap between vascular interventions and vascular medicine

Ribichini F, Tomai F, Castriota F, Russo P, Reimers B

May 25, 2010

Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levels

Ferrero V, Tomai F, Versaci F, Feola M, Proietti I, Rognoni A, Ghini A, Gaspardone A, Vacca G, De Luca L, Vassanelli C, Ribichini F

June 30, 2009

On the current epidemic outburst of meta-analytic rage in interventional cardiology

Agostoni P, Ribichini F, Wijns W

May 19, 2009

Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD study

Ribichini F, Tomai F, Ferrero V, Versaci F, Boccuzzi G, Proietti I, Prati F, Crea F, Vassanelli C

August 20, 2005

Latest news

New issue

TAVR in sarcopaenia; CCTA or TEE in LAAC; Iintravascular lithotripsy, read the new issue

(CT scans of a sarcopaenic patient)

October 18, 2019

Free access

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

Free Access

New this week: Insights from an International CTO Registry

October 22, 2019

Free access

Guidelines, consensus & position papers

April 9, 2019

Editorial

When is it best to stop aspirin and who could ultimately benefit?

Aspirin-free antiplatelet regimens after PCI

October 9, 2019

Free access

The EuroIntervention health check 2019

October 4, 2019

Free Access

Last week's JAA: Hydrodynamic function with the ALLEGRA heart valve

October 15, 2019

Flavio Ribichini

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke